Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Gap Dec. Comps. Rise; Board OKs $1 Bln Buyback - Quick Facts

RELATED NEWS
Trade GPS now with 

Fashion retailer Gap Inc. (GPS: Quote) said its December 2012 comparable sales went up 5 percent, compared with a 4 percent decline for December 2011. Net sales for the five-week period were $2.08 billion, higher than $1.98 billion a year earlier.

Separately, the company reported the board's approval of a new $1 billion share repurchase authorization for the company's common stock, reinforcing the company's commitment to returning excess cash to shareholders. This new $1 billion buyback program follows the company's prior $1 billion share repurchase, which was completed during the fourth quarter of fiscal year 2012.

The company repurchased nearly 17 million shares for about $539 million in the fourth quarter of fiscal year 2012 to date.

Click here to receive FREE breaking news email alerts for Gap Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
President Barack Obama sought to emphasize in remarks on Wednesday that the American forces being deployed as part of the fight against the terrorist group ISIS will not have a combat mission. While buying interest has remained somewhat subdued, stocks continue to see modest strength in mid-day trading on Wednesday. The Dow has pulled back off its new record intraday high but remains in positive territory. Republican Joni Ernst has moved into the lead in the potentially crucial Iowa Senate race, according to the results of a Quinnipiac University poll released on Wednesday. The poll found that 50 percent of likely Iowa voters would support Ernst if the election were held today, while 44 percent would vote for Democratic Rep. Bruce Braley.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.